In line with these findings, inhibition of glutaminase sensitized cisplatin-resistant ovarian cancers to chemotherapy (110, 110) and also the inhibition of FASN with orlistat enhanced the efficacy of cisplatin in ovarian cancers (111). Here, GLS is linked to ovarian cancer.